Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects

OBJECTIVE: This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in overweight to moderately obese adults. METHODS: A double-blind, randomized, placebo-controlled trial involved one hundred and eight subjects (BMI between 25 and 35 kg/m(2))...

Descripción completa

Detalles Bibliográficos
Autores principales: Uebelhack, Ralf, Bongartz, Udo, Seibt, Stephanie, Bothe, Gordana, Chong, Pee Win, De Costa, Patricia, Wszelaki, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377993/
https://www.ncbi.nlm.nih.gov/pubmed/30863632
http://dx.doi.org/10.1155/2019/3412952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377993/
https://www.ncbi.nlm.nih.gov/pubmed/30863632
http://dx.doi.org/10.1155/2019/3412952

Ejemplares similares